Janus Henderson Group PLC Emergent Bio Solutions Inc. Transaction History

Janus Henderson Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $174 - $435	55 Added 0.27%	20,359 $69,000
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $323 - $581	-44 Reduced 0.22%	20,304 $149,000
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $366,316 - $766,020	-47,024 Reduced 69.8%	20,348 $210,000
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $53,471 - $104,268	-4,861 Reduced 6.73%	67,372 $795,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $17,397 - $31,002	-866 Reduced 1.18%	72,233 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $19.7 Million - $31.4 Million	-720,233 Reduced 90.79%	73,099 $2.27 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $37.6 Million - $53.8 Million	-1,029,549 Reduced 56.48%	793,332 $32.6 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $34.7 Million - $57.6 Million	-1,047,022 Reduced 36.48%	1,822,881 $79.2 Million
Q3 2021 Nov 16, 2021	SELL	$50.07 - $66.05 $39 Million - $51.5 Million	-779,066 Reduced 21.35%	2,869,903 $144 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $50.3 Million - $71.5 Million	889,033 Added 32.21%	3,648,969 $230 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $157 Million - $227 Million	1,815,872 Added 192.35%	2,759,936 $256 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $74.7 Million - $105 Million	944,064 New	944,064 $84.6 Million
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $195,784 - $225,397	-4,051 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $180,026 - $220,333	4,051 New	4,051 $213,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.